MedPath

RIXUBIS

RIXUBIS

Approved
DIN Number

02431963

Drug Class

Human

Market Date

Sep 25, 2018

Company
HC

takeda canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02431963
AIG Number0156050005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD04 COAGULATION FACTOR IX
Product Specifications
Dosage FormKit ,  Powder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

NONACOG GAMMAActive
Strength: 3000 UNIT / VIAL
Monograph: NONACOG GAMMA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.